Clinical Trials Directory

Trials / Conditions / Autologous Stem Cell Transplant

Autologous Stem Cell Transplant

7 registered clinical trials studyying Autologous Stem Cell Transplant — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingMT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
NCT06377540
Masonic Cancer Center, University of MinnesotaPhase 2
RecruitingHigh Heated Humidity in Stem Cell Transplant
NCT05358262
AHS Cancer Control AlbertaPhase 2
Active Not RecruitingIsatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM
NCT04653246
Jacob Laubach, MDPhase 2
CompletedDetermining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients
NCT04783038
Mayo ClinicN/A
CompletedA Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following
NCT02181413
TakedaPhase 3
CompletedBendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant
NCT01296256
Grupo Español de Linfomas y Transplante Autólogo de Médula ÓseaPhase 2
Approved For MarketingAccess Program for Use of AMD3100 to Increase Peripheral Blood Stem Cells for Transplantation in Patients Who
NCT00291811
Genzyme, a Sanofi Company—